Schedule 13G ownership disclosure

PIERIS PHARMACEUTICALS INC

Security class unavailable · CUSIP: 720795103

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,848,191
Percent of class
9.7000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-096168
Form type
SC 13G
Filer
PALVELLA THERAPEUTICS, INC.
CIK
CIK 1583648
Filed
Feb 12, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub